Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Lartruvo (olaratumab)
i
Other names:
IMC-3G3, IMC 3G3, LY 3012207, LY3012207, anti-PDGFRα mAb 3G3
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Eli Lilly
Drug class:
PDGFR α antagonist
Related drugs:
‹
lenvatinib (90)
CS 2164 (1)
lenvatinib (90)
CS 2164 (1)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
olaratumab
Sensitive: A1 - Approval
olaratumab
Sensitive
:
A1
olaratumab
Sensitive: A1 - Approval
olaratumab
Sensitive
:
A1
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login